login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
RECURSION PHARMACEUTICALS-A (RXRX) Stock News
USA
- NASDAQ:RXRX -
US75629V1044
-
Common Stock
4.16
USD
+0.04 (+0.97%)
Last: 11/18/2025, 10:31:14 PM
4.15
USD
-0.01 (-0.24%)
After Hours:
11/18/2025, 10:31:14 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
RXRX Latest News, Press Relases and Analysis
All
Press Releases
14 days ago - By: Chartmill
Recursion Pharmaceuticals (NASDAQ:RXRX) Reports Q3 2025 Results with Revenue Miss and Extended Cash Runway
14 hours ago - By: MarketNewsUpdates.com
- Mentions:
AVAI
NTLA
ZYME
ANVS
Longevity-Focused Health Fueling U.S. Anti-Aging Products Market Projected to Reach $27 Billion By 2033
7 days ago - By: The Motley Fool
- Mentions:
LLY
NVDA
Forget Recursion Pharmaceuticals: This Could Be an Even Better Artificial Intelligence (AI) Stock
14 days ago - By: Zacks Investment Research
- Mentions:
IVVD
Recursion Pharmaceuticals (RXRX) Reports Q3 Loss, Misses Revenue Estimates
14 days ago - By: Recursion Pharmaceuticals
Recursion Reports Third Quarter 2025 Financial Results and Provides Business Update
14 days ago - By: Recursion Pharmaceuticals
Recursion Reports Third Quarter 2025 Financial Results and Provides Business Update
14 days ago - By: Recursion Pharmaceuticals
Recursion Announces CEO Transition Plan to Drive Next Phase of Growth
14 days ago - By: Recursion Pharmaceuticals
Recursion Announces CEO Transition Plan to Drive Next Phase of Growth
14 days ago - By: Benzinga
- Mentions:
TECH
INSE
GEF
SKYT
...
Earnings Scheduled For November 5, 2025
15 days ago - By: Recursion Pharmaceuticals
Recursion to Participate in Upcoming Investor Conferences
15 days ago - By: Zacks Investment Research
- Mentions:
ANIP
CRSP
IMCR
Recursion Pharmaceuticals to Report Q3 Earnings: What's in the Cards?
21 days ago - By: Zacks Investment Research
- Mentions:
NAGE
Earnings Preview: Recursion Pharmaceuticals (RXRX) Q3 Earnings Expected to Decline
22 days ago - By: Recursion Pharmaceuticals
Recursion to Report Third Quarter 2025 Business Updates and Financial Results on November 5th
22 days ago - By: Recursion Pharmaceuticals
Recursion to Report Third Quarter 2025 Business Updates and Financial Results on November 5th
a month ago - By: Benzinga
- Mentions:
OPEN
PLUG
AI
GME
...
Looking For The Next Beyond Meat? Here Are The Top 10 Most Shorted Stocks
a month ago - By: The Motley Fool
Recursion Pharmaceuticals (RXRX) CEO Sells 100,000 Shares
2 months ago - By: Zacks Investment Research
Recursion Pharmaceuticals (RXRX) Stock Sinks As Market Gains: What You Should Know
Please enable JavaScript to continue using this application.